Your browser is no longer supported. Please, upgrade your browser.
Settings
IDXG [NASD]
Interpace Biosciences, Inc.
Index- P/E- EPS (ttm)-8.67 Insider Own5.70% Shs Outstand4.04M Perf Week-3.28%
Market Cap18.69M Forward P/E- EPS next Y-1.71 Insider Trans0.00% Shs Float3.75M Perf Month23.74%
Income-33.90M PEG- EPS next Q-0.94 Inst Own17.10% Short Float3.28% Perf Quarter8.58%
Sales26.40M P/S0.71 EPS this Y-55.00% Inst Trans- Short Ratio0.85 Perf Half Y-19.89%
Book/sh-5.40 P/B- EPS next Y68.60% ROA-55.20% Target Price- Perf Year-37.39%
Cash/sh1.26 P/C3.53 EPS next 5Y15.00% ROE231.60% 52W Range2.57 - 11.00 Perf YTD41.08%
Dividend- P/FCF- EPS past 5Y39.30% ROI2267.30% 52W High-59.73% Beta1.08
Dividend %- Quick Ratio1.00 Sales past 5Y75.00% Gross Margin23.60% 52W Low72.23% ATR0.33
Employees176 Current Ratio1.10 Sales Q/Q6.50% Oper. Margin-92.60% RSI (14)63.68 Volatility8.64% 8.81%
OptionableNo Debt/Eq- EPS Q/Q21.80% Profit Margin- Rel Volume0.90 Prev Close4.30
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume144.85K Price4.43
Recom1.70 SMA2015.99% SMA5028.07% SMA2003.32% Volume130,827 Change3.02%
Apr-15-20Initiated Janney Buy
Sep-26-19Initiated Oppenheimer Outperform $3
Feb-22-18Initiated Laidlaw Buy $4.50
Feb-14-18Reiterated Maxim Group Buy $5 → $3
Aug-15-17Initiated Maxim Group Buy $5
Jan-21-21 02:30PM  
Jan-20-21 03:38PM  
08:30AM  
Nov-25-20 08:12AM  
Nov-19-20 04:11PM  
Oct-26-20 06:30AM  
Oct-20-20 08:00AM  
Oct-14-20 06:30AM  
Aug-20-20 08:30AM  
Aug-13-20 07:46PM  
Jul-21-20 06:05AM  
Jun-25-20 04:59PM  
Jun-24-20 04:20PM  
Jun-10-20 03:48PM  
Apr-27-20 06:55AM  
Apr-22-20 04:05PM  
01:38PM  
Mar-11-20 09:25PM  
Mar-10-20 06:55AM  
Mar-02-20 06:55AM  
Feb-24-20 06:55AM  
Feb-11-20 06:55AM  
Jan-30-20 06:55AM  
Jan-13-20 06:55AM  
Jan-08-20 07:33AM  
Jan-06-20 06:55AM  
Dec-17-19 06:55AM  
Dec-05-19 06:55AM  
Dec-02-19 06:55AM  
Nov-13-19 04:40PM  
Nov-12-19 06:55AM  
Nov-04-19 06:55AM  
Oct-29-19 06:55AM  
Oct-24-19 04:15PM  
06:55AM  
Oct-17-19 06:55AM  
Oct-15-19 07:51AM  
06:55AM  
Sep-30-19 06:55AM  
Sep-18-19 06:55AM  
Sep-16-19 06:55AM  
Sep-06-19 06:55AM  
Aug-20-19 05:44PM  
Aug-19-19 05:15PM  
Aug-13-19 08:15AM  
06:30AM  
Aug-06-19 04:05PM  
Jul-31-19 06:55AM  
Jul-29-19 06:55AM  
Jul-22-19 06:55AM  
Jul-18-19 09:05AM  
06:55AM  
Jul-16-19 08:44AM  
Jul-15-19 04:10PM  
11:04AM  
Jun-20-19 06:55AM  
Jun-13-19 06:55AM  
May-27-19 05:06PM  
May-13-19 04:05PM  
May-09-19 06:55AM  
May-06-19 06:55AM  
May-01-19 06:55AM  
Apr-29-19 08:28AM  
Apr-25-19 06:55AM  
Apr-23-19 06:55AM  
Apr-02-19 06:55AM  
Mar-21-19 06:48PM  
04:36PM  
Mar-19-19 04:05PM  
Mar-07-19 01:46PM  
Mar-04-19 06:55AM  
Feb-28-19 06:55AM  
Feb-19-19 06:55AM  
Feb-04-19 06:55AM  
Jan-29-19 04:20PM  
Jan-25-19 06:00AM  
Jan-24-19 04:35PM  
06:55AM  
Jan-22-19 06:55AM  
Jan-18-19 12:54PM  
Jan-14-19 06:55AM  
Dec-27-18 06:55AM  
Dec-21-18 10:39AM  
Dec-17-18 06:50AM  
Dec-07-18 07:45AM  
Nov-28-18 06:55AM  
Nov-27-18 09:48AM  
Nov-26-18 06:55AM  
Nov-13-18 04:17PM  
Nov-09-18 06:55AM  
Nov-07-18 08:06AM  
Nov-06-18 06:55AM  
Nov-05-18 10:30AM  
Oct-30-18 08:45AM  
Oct-24-18 06:55AM  
Oct-22-18 06:55AM  
Oct-15-18 06:55AM  
Oct-10-18 08:30AM  
Oct-04-18 06:55AM  
Oct-01-18 06:55AM  
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.